RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Genomic sequencing in diverse and underserved pediatric populations
Parent perspectives on understanding, uncertainty, psychosocial impact, and personal utility of results
Biesecker, B. B., Ackerman, S. L., Brothers, K. B., East, K. M., Katherine M Foreman, A., Hindorff, L. A., Horowitz, C. R., Jarvik, G. P., Knight, S. J., Leo, M. C., Patrick, D. L., Rini, C., Robinson, J. O., Sahin-Hodoglugil, N. N., Slavotinek, A., Suckiel, S. A., Veenstra, D. L., Zinberg, R. E., & Hunter, J. E. (2025). Genomic sequencing in diverse and underserved pediatric populations: Parent perspectives on understanding, uncertainty, psychosocial impact, and personal utility of results. Genetics in Medicine, 27(4), 101363. Article 101363. https://doi.org/10.1016/j.gim.2025.101363
Purpose: Limited evidence evaluates parents' perceptions of their child's clinical genome-scale sequencing (GS) results, particularly among individuals from medically underserved groups. Five Clinical Sequencing Evidence-Generating Research consortium studies performed GS in children with suspected genetic conditions with high proportions of individuals from underserved groups to address this evidence gap. Methods: Parents completed surveys of perceived understanding, personal utility, and test- related distress after GS result disclosure. We assessed outcomes' associations with child- and parent-related factors: child age; type of GS finding; and parent health literacy, numeracy, and education. Results: A total of 1763 parents completed surveys; 83% met "underserved" criteria based on race, ethnicity, and risk factors for barriers to access. We observed high perceived understanding and personal utility and low test-related distress. Outcomes were associated with the type of GS finding; parents of children with a pathogenic or likely pathogenic finding endorsed higher personal utility and more test-related distress than those whose children had a variant of uncertain significance or normal finding. Personal utility was higher in parents who met the criteria for "underserved." Conclusion: Our findings shed light on correlates of parents' cognitive and emotional responses to their child's GS findings and emphasize the need for tailored support in disclosure discussions. (c) 2025 by American College of Medical Genetics and Genomics. Published by Elsevier Inc.
